Glenn Yiu, MD, PhD
University of California, Davis
Dr. Yiu is a vitreoretinal surgeon and clinician-scientist at UC Davis. He earned his dual MD-PhD degrees at Harvard Medical School, underwent residency training at the Massachusetts Eye & Ear Infirmary, and got his fellowship training at the Duke Eye Center. He is currently involved in translational research in AMD and other retinal diseases. His focuses include ocular imaging technologies, gene editing, drug delivery, and primate models of retinal disease. He described the first use of CRISPR-based genome editing as a treatment strategy for wet AMD, and pioneered work to study macular degeneration features in rhesus monkeys. He also employs advanced ocular imaging to manipulate drug delivery, create an optogenetic model of geographic atrophy, and understand the pathophysiology of AMD. He has published numerous peer-reviewed scientific papers and book chapters, serves as a course lecturer at the American Academy of Ophthalmology, and and is the editor of the textbook “Vitreoretinal Disorders.” Dr. Yiu has received numerous awards including the Ronald G. Michels Foundation Fellowship Award, the Heed Ophthalmic Foundation Fellowship Award, the Retina Society Fellowship Research Award, and the Macula Society Evangelos S. Gragoudas Award. He also received the E Matilda Ziegler Foundation research grant, the ARVO Foundation Genentech AMD Fellowship, the Alcon Research Institute Young Investigator Award, and is supported by a K08 career-development award from the National Eye Institute. In 2016, he was named as one of 21 “Emerging Vision Scientists” by the National Alliance for Eye and Vision Research for his cutting-edge research.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.